Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Dutasteride may help prevent prostate cancer, but more research is needed.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

PDGF signaling is crucial for cell development, wound healing, and fluid regulation in the body.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Progesterone protects brain cells, but Provera does not.

New drug uses show promise but need more research.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

AH-001 could be a safer and more effective treatment for hair loss.

DPCP is more effective than tretinoin gel for treating severe alopecia.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Dutasteride is a safe and effective treatment for hair loss.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Drugs that block GSK-3 show promise for treating various diseases.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.